These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8458046)

  • 61. Home intravenous antibiotic therapy.
    Scully BE
    N J Med; 1992 Jan; 89(1):48-51. PubMed ID: 1542453
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Researchers find huge savings opportunity in oral form of IV drugs.
    ED Manag; 2012 Jan; 24(1):9-11. PubMed ID: 22413732
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Benefits to hospitals of sole home infusion therapy providers.
    Enriquez N; Conte R
    Am J Hosp Pharm; 1992 Nov; 49(11):2707-8. PubMed ID: 1471633
    [No Abstract]   [Full Text] [Related]  

  • 64. Secondary bacterial infections in HIV-infected patients: an alternative ambulatory outpatient treatment utilizing intravenous cefotaxime.
    Morales JO; Von Behren L
    Am J Med; 1994 Aug; 97(2A):9-13. PubMed ID: 8059803
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Therapeutic exchange of cefotaxime for ceftriaxone: evaluation, implementation, and subsequent cost savings at a 300-bed community hospital.
    Rawlings RD
    Diagn Microbiol Infect Dis; 1995; 22(1-2):235-7. PubMed ID: 7587046
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Treatment of skin and soft-tissue infections utilizing an outpatient parenteral drug delivery device: a multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):23-7. PubMed ID: 8059797
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Self-administration of intravenous antibiotics: an efficient, cost-effective home care program.
    Stiver HG; Trosky SK; Cote DD; Oruck JL
    Can Med Assoc J; 1982 Aug; 127(3):207-11. PubMed ID: 6809305
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Use of outpatient parenteral antibiotic therapy in a health maintenance organization.
    Grizzard MB; Harris G; Karns H
    Rev Infect Dis; 1991; 13 Suppl 2():S174-9. PubMed ID: 2017648
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Intravenous antibiotic therapy in an outpatient setting.
    Poretz DM; Eron LJ; Goldenberg RI; Gilbert AF; Rising J; Sparks S; Horn CE
    JAMA; 1982 Jul; 248(3):336-9. PubMed ID: 7087128
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of use-criteria for intravenous administration sets.
    Hartwig SC; Hanson AL; Thielke TS
    Am J Hosp Pharm; 1986 Dec; 43(12):3003-8. PubMed ID: 3812507
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Problems of infection in drug addicts and current possibilities of treatment].
    Rolloni M; Del Litto MP; Ialongo A; Sampalmieri G
    Minerva Med; 1985 Apr; 76(14-15):729-32. PubMed ID: 3991035
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Treatment of bone and joint infections utilizing a third-generation cephalosporin with an outpatient drug delivery device. HIAT Study Group.
    Mauceri AA
    Am J Med; 1994 Aug; 97(2A):14-22. PubMed ID: 8059796
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pediatric outpatient parenteral antimicrobial therapy: an update.
    Maraqa NF; Rathore MH
    Adv Pediatr; 2010; 57(1):219-45. PubMed ID: 21056740
    [No Abstract]   [Full Text] [Related]  

  • 74. Economics of home intravenous services.
    Thickson ND
    Pharmacoeconomics; 1993 Mar; 3(3):220-7. PubMed ID: 10146945
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Treatment of serious infections with cefotaxime utilizing an outpatient drug delivery device: global analysis of a large-scale, multicenter trial. HIAT Study Group.
    Poretz DM
    Am J Med; 1994 Aug; 97(2A):34-42. PubMed ID: 8059800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Outpatient treatment of serious infections in infants and children with ceftriaxone.
    Powell KR; Mawhorter SD
    J Pediatr; 1987 Jun; 110(6):898-901. PubMed ID: 3585606
    [No Abstract]   [Full Text] [Related]  

  • 77. Use of cefotaxime at Kenyatta National Hospital.
    Shah MV; Kanja C
    East Afr Med J; 1983 Mar; 60(3):196-9. PubMed ID: 6311510
    [No Abstract]   [Full Text] [Related]  

  • 78. Retrospective analysis of the clinical and economic outcomes of twice-daily dosing of cefotaxime in a Canadian tertiary care institution.
    Tin LY; Pitre M; Conly JM
    Diagn Microbiol Infect Dis; 1995; 22(1-2):135-40. PubMed ID: 7587028
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cefotaxime therapy for serious infections.
    Tanphaichitra D; Wanvarie S; Srimuang S
    J Med Assoc Thai; 1984 Feb; 67(2):108-10. PubMed ID: 6330259
    [No Abstract]   [Full Text] [Related]  

  • 80. Intravenous administration of human immune globulin.
    Rutherford C
    J Intraven Nurs; 1989; 12(5):307-9. PubMed ID: 2795332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.